Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Corbus Pharmaceuticals appointed Leonardo Viana Nicacio, M.D. as Chief Medical Officer, bringing over 20 years of experience in oncology drug development to the clinical-stage company. Dr. Nicacio’s background includes advancing the ADC TIVDAK at Seagen, which aligns with Corbus’s strategic focus on CRB-701, a next-generation ADC for Nectin-4-expressing tumors.
Key figures
- Tempo 1 n
- 250
- Canyon 1 n
- 240
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.